II. Indications
- Hospitalized Patients with Acute Severe Pain (e.g. Sickle Cell Crisis, Acute Pancreatitis, Burn Injury)
- Severe Acute Exacerbation of Chronic Pain (e.g. metastatic cancer)
- Perioperative Pain Management
- Labor Analgesia
III. Contraindications
- Inadequate capacity or mental status to understand pump use
- High risk for respiratory depression (e.g. severe Sleep Apnea)
IV. Technique
- Medications- Opioid Analgesics (IV, epidural)
- Local Anesthetics (epidural, Peripheral Nerve catheter)- Ropivacaine is the safest of the Regional AnesthesiaLocal Anesthetics
- Other regional Anesthetics include Bupivacaine, levobupivacaine
 
 
- Routes- Intravenous analgesia- See Opioid Analgesic
 
- Epidural Analgesia
- Peripheral Nerve catheter with Local Anesthetic (e.g. Ropivacaine)
- Transdermal analgesia
 
- Intravenous analgesia
- Ordering- PCA Pump use relies on clinicians, pharmacists and nurses to ensure safe initiation and maintenance
- Patients must understand the use of the PCA Pump (e.g. when to press the button, frequency and lockout)
- Patient visitors should be cautioned not to press the button for the patient
- Machine access should be secured for modification only by staff, to prevent machine tampering
 
V. Evaluation
VI. Adverse Effects
- See specific agents infused (e.g. Morphine)
- 
                          Opioid Adverse Effects- Examples: Vomiting, Constipation, Pruritus, respiratory depression
 
- 
                          Local Anesthetic Adverse Effects- See LAST Reaction
 
VII. Complications
- PCA Pump malfunction or misuse resulting in Opioid Overdose (risk of lethal Overdose)- Runaway pump- Excessive frequency or dose
 
- IV Anti-reflux valve malfunction- Opioid refluxes into main IV infusion
 
- Medication Syringe malfunction- Entire contents of syringe administered on initiation
 
- PCA by proxy- Person other than the patient (e.g. family) presses the button to administer additional medication
 
 
- Runaway pump
- Epidural catheter and Peripheral Nerve catheter complications- Infected line- Risk of Spinal Infection or deep tissue infection
 
- Dislodged or migrated catheter- Risk of longterm nerve injury
 
 
- Infected line
VIII. Efficacy
- Patients- Offers more effective pain control and greater patient satisfaction
- Amount of Opioids use may be higher than what would have been used without PCA Pump
 
- Nurses- Reduced overall nursing workload when frequent Analgesic dosing is need
 
- Costs- Does not prolong hospital length of stay
- PCA Pump costs are higher than nurse administered dosing
 
IX. Management: Step 1 - Calculate hourly dose for Morphine
X. Management: Step 2: Set Lockout periods and Maximums
XI. Management: Step 3: Consider Background Continuous Infusion
- Indications- Opioid Dependence
- Severe pain on awakening
 
- Calculation- Set background rate <50% of anticipated requirements
- Typical adult background Morphine rate: 1 mg/hour
 
XII. Management: Step 4: Determine PCA bolus Dose
XIII. Management: Step 5: Convert from Morphine to other Opioid
- 
                          Hydromorphone (Dilaudid)- Dose Estimate: 1.5 mg per Morphine 10 mg
- Typical bolus: 0.25 mg
- Lockout: 5-10 min
- Increased CNS side effects including excitation at high dose
 
- Fentanyl
- Sufentanil- Typical bolus: 5 mcg/kg
- Lockout: 5-10 min
- High potency, short duration and may require basal infusion rate
- Less Postoperative Nausea and Vomiting than Fentanyl
- Avoid in Obesity due to prolonged Half-Life (use Morphine instead)
 
XIV. Management: Examples for Typical 30 year old
- 
                          Morphine
                          - Boluses: 1 mg
- Background infusion rate: 1 mg/hour (optional)
- Hourly maximum: 10 mg
- Lockout: 6 minutes
 
- 
                          Hydromorphone (Dilaudid)- Boluses: 0.1 mg
- Background infusion rate: 0.1 mg/hour (optional)
- Hourly maximum: 1.5 mg
- Lockout: 6 minutes
 
XV. References
- Pastino (2024) Patient-Controlled Analgesia, StatPearls, FL, accessed 11/4/2024
- Etches (1999) Surg Clin North Am 79(2):297-312 [PubMed]
- Motamed (2024) Pharmacy 10(1):22 +PMID: 35202071 [PubMed]
